Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Corvus Pharmaceuticals (CRVS) Return on Assets (2022 - 2025)

Corvus Pharmaceuticals (CRVS) has 4 years of Return on Assets data on record, last reported at 0.02% in Q3 2025.

  • For Q3 2025, Return on Assets rose 87.0% year-over-year to 0.02%; the TTM value through Sep 2025 reached 0.02%, up 87.0%, while the annual FY2023 figure was 0.41%, N/A changed from the prior year.
  • Return on Assets reached 0.02% in Q3 2025 per CRVS's latest filing, up from 0.42% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.02% in Q3 2025 and bottomed at 0.89% in Q3 2024.
  • Average Return on Assets over 4 years is 0.48%, with a median of 0.45% recorded in 2022.
  • Peak YoY movement for Return on Assets: tumbled -49bps in 2024, then surged 87bps in 2025.
  • A 4-year view of Return on Assets shows it stood at 0.44% in 2022, then dropped by -4bps to 0.45% in 2023, then tumbled by -69bps to 0.77% in 2024, then soared by 97bps to 0.02% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.02% in Q3 2025, 0.42% in Q2 2025, and 0.43% in Q1 2025.